Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
M Alyami, M Hübner, F Grass, N Bakrin… - The Lancet …, 2019 - thelancet.com
Pressurised intraperitoneal aerosol chemotherapy (PIPAC) was introduced as a new
treatment for patients with peritoneal metastases in November, 2011. Reports of its …
treatment for patients with peritoneal metastases in November, 2011. Reports of its …
[HTML][HTML] Colorectal cancer: Metastases to a single organ
Colorectal cancer (CRC) is a common malignancy worldwide. In CRC patients, metastases
are the main cause of cancer-related mortality. In a group of metastatic CRC patients, the …
are the main cause of cancer-related mortality. In a group of metastatic CRC patients, the …
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a …
F Quénet, D Elias, L Roca, D Goéré, L Ghouti… - The Lancet …, 2021 - thelancet.com
Background The addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to
cytoreductive surgery has been associated with encouraging survival results in some …
cytoreductive surgery has been associated with encouraging survival results in some …
The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of colon cancer
METHODS This guideline is based on the previous colon cancer parameter published in
2017. 10 Compared with 2017, this guideline has 11 new, 10 updated, and 2 excluded …
2017. 10 Compared with 2017, this guideline has 11 new, 10 updated, and 2 excluded …
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases …
D Goéré, O Glehen, F Quenet, JM Guilloit… - The Lancet …, 2020 - thelancet.com
Background Diagnosis and treatment of colorectal peritoneal metastases at an early stage,
before the onset of signs, could improve patient survival. We aimed to compare the survival …
before the onset of signs, could improve patient survival. We aimed to compare the survival …
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score …
PE Bonnot, G Piessen, V Kepenekian… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE Gastric cancer (GC) with peritoneal metastases (PMs) is a poor prognostic
evolution. Cytoreductive surgery (CRS) yields promising results, but the impact of …
evolution. Cytoreductive surgery (CRS) yields promising results, but the impact of …
The American Society of Colon and Rectal Surgeons clinical practice guidelines for the treatment of colon cancer
Abstract The American Society of Colon and Rectal Surgeons is dedicated to ensuring high-
quality patient care by advancing the science, prevention, and management of disorders …
quality patient care by advancing the science, prevention, and management of disorders …
[HTML][HTML] ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making
HJ Schmoll, E Van Cutsem, A Stein, V Valentini… - Annals of oncology, 2012 - Elsevier
Colorectal cancer (CRC) is the most common tumour type in both sexes combined in
Western countries. Although screening programmes including the implementation of faecal …
Western countries. Although screening programmes including the implementation of faecal …
Thermosensitive exosome–liposome hybrid nanoparticle‐mediated chemoimmunotherapy for improved treatment of metastatic peritoneal cancer
Q Lv, L Cheng, Y Lu, X Zhang, Y Wang… - Advanced …, 2020 - Wiley Online Library
Metastatic peritoneal carcinoma (mPC) is a deadly disease without effective treatment. To
improve treatment of this disease, a recently developed hyperthermic intraperitoneal …
improve treatment of this disease, a recently developed hyperthermic intraperitoneal …
[HTML][HTML] Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?
Colorectal cancer commonly metastasizes. The liver is the most frequent site of metastases
and dominates the length of survival for this disease. As surgical and systemic therapies …
and dominates the length of survival for this disease. As surgical and systemic therapies …